aluates Reports

$ 0.0

Automative

Global Abdominal Aortic Aneurysm Drug Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-2G7537

Global Abdominal Aortic Aneurysm Drug Market Insights Forecast to 2028

BUY CHAPTERS

Global Abdominal Aortic Aneurysm Drug Market Research Report 2025

Code: QYRE-Auto-2G7537

Report

September 2025

Pages:69

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Astrazeneca plc

Carolus Therapeutics, Inc.

Novartis

Vida Therapeutics Inc.

Abdominal Aortic Aneurysm Drug Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Abdominal Aortic Aneurysm Drug Market

The global market for Abdominal Aortic Aneurysm Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Abdominal Aortic Aneurysm Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Abdominal Aortic Aneurysm Drug.

The Abdominal Aortic Aneurysm Drug market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Abdominal Aortic Aneurysm Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Abdominal Aortic Aneurysm Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Abdominal Aortic Aneurysm Drug Market Report

Report Metric	Details
Report Name	Abdominal Aortic Aneurysm Drug Market
CAGR	5%
Segment by Type	BSN-908 Canakinumab CT-2009 Ticagrelor Others
Segment by Application	Hospital Clinic Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	AstraZeneca Plc, Carolus Therapeutics, Inc., Novartis AG, Vida Therapeutics Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Abdominal Aortic Aneurysm Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Abdominal Aortic Aneurysm Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Abdominal Aortic Aneurysm Drug Market report?

Ans: The main players in the Abdominal Aortic Aneurysm Drug Market are AstraZeneca Plc, Carolus Therapeutics, Inc., Novartis AG, Vida Therapeutics Inc.

What are the Application segmentation covered in the Abdominal Aortic Aneurysm Drug Market report?

Ans: The Applications covered in the Abdominal Aortic Aneurysm Drug Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Abdominal Aortic Aneurysm Drug Market report?

Ans: The Types covered in the Abdominal Aortic Aneurysm Drug Market report are BSN-908, Canakinumab, CT-2009, Ticagrelor, Others

1 Abdominal Aortic Aneurysm Drug Market Overview

1.1 Product Definition

1.2 Abdominal Aortic Aneurysm Drug by Type

1.2.1 Global Abdominal Aortic Aneurysm Drug Market Value Comparison by Type (2024 VS 2031)

1.2.2 BSN-908

1.2.3 Canakinumab

1.2.4 CT-2009

1.2.5 Ticagrelor

1.2.6 Others

1.3 Abdominal Aortic Aneurysm Drug by Application

1.3.1 Global Abdominal Aortic Aneurysm Drug Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Global Abdominal Aortic Aneurysm Drug Market Size Estimates and Forecasts

1.4.1 Global Abdominal Aortic Aneurysm Drug Revenue 2020-2031

1.4.2 Global Abdominal Aortic Aneurysm Drug Sales 2020-2031

1.4.3 Global Abdominal Aortic Aneurysm Drug Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Abdominal Aortic Aneurysm Drug Market Competition by Manufacturers

2.1 Global Abdominal Aortic Aneurysm Drug Sales Market Share by Manufacturers (2020-2025)

2.2 Global Abdominal Aortic Aneurysm Drug Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Abdominal Aortic Aneurysm Drug Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Abdominal Aortic Aneurysm Drug, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Abdominal Aortic Aneurysm Drug, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Abdominal Aortic Aneurysm Drug, Product Type & Application

2.7 Global Key Manufacturers of Abdominal Aortic Aneurysm Drug, Date of Enter into This Industry

2.8 Global Abdominal Aortic Aneurysm Drug Market Competitive Situation and Trends

2.8.1 Global Abdominal Aortic Aneurysm Drug Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Abdominal Aortic Aneurysm Drug Players Market Share by Revenue

2.8.3 Global Abdominal Aortic Aneurysm Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Abdominal Aortic Aneurysm Drug Market Scenario by Region

3.1 Global Abdominal Aortic Aneurysm Drug Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Abdominal Aortic Aneurysm Drug Sales by Region: 2020-2031

3.2.1 Global Abdominal Aortic Aneurysm Drug Sales by Region: 2020-2025

3.2.2 Global Abdominal Aortic Aneurysm Drug Sales by Region: 2026-2031

3.3 Global Abdominal Aortic Aneurysm Drug Revenue by Region: 2020-2031

3.3.1 Global Abdominal Aortic Aneurysm Drug Revenue by Region: 2020-2025

3.3.2 Global Abdominal Aortic Aneurysm Drug Revenue by Region: 2026-2031

3.4 North America Abdominal Aortic Aneurysm Drug Market Facts & Figures by Country

3.4.1 North America Abdominal Aortic Aneurysm Drug Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Abdominal Aortic Aneurysm Drug Sales by Country (2020-2031)

3.4.3 North America Abdominal Aortic Aneurysm Drug Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Abdominal Aortic Aneurysm Drug Market Facts & Figures by Country

3.5.1 Europe Abdominal Aortic Aneurysm Drug Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Abdominal Aortic Aneurysm Drug Sales by Country (2020-2031)

3.5.3 Europe Abdominal Aortic Aneurysm Drug Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Abdominal Aortic Aneurysm Drug Market Facts & Figures by Region

3.6.1 Asia Pacific Abdominal Aortic Aneurysm Drug Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Abdominal Aortic Aneurysm Drug Sales by Region (2020-2031)

3.6.3 Asia Pacific Abdominal Aortic Aneurysm Drug Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Abdominal Aortic Aneurysm Drug Market Facts & Figures by Country

3.7.1 Latin America Abdominal Aortic Aneurysm Drug Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Abdominal Aortic Aneurysm Drug Sales by Country (2020-2031)

3.7.3 Latin America Abdominal Aortic Aneurysm Drug Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Abdominal Aortic Aneurysm Drug Market Facts & Figures by Country

3.8.1 Middle East and Africa Abdominal Aortic Aneurysm Drug Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Abdominal Aortic Aneurysm Drug Sales by Country (2020-2031)

3.8.3 Middle East and Africa Abdominal Aortic Aneurysm Drug Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Abdominal Aortic Aneurysm Drug Sales by Type (2020-2031)

4.1.1 Global Abdominal Aortic Aneurysm Drug Sales by Type (2020-2025)

4.1.2 Global Abdominal Aortic Aneurysm Drug Sales by Type (2026-2031)

4.1.3 Global Abdominal Aortic Aneurysm Drug Sales Market Share by Type (2020-2031)

4.2 Global Abdominal Aortic Aneurysm Drug Revenue by Type (2020-2031)

4.2.1 Global Abdominal Aortic Aneurysm Drug Revenue by Type (2020-2025)

4.2.2 Global Abdominal Aortic Aneurysm Drug Revenue by Type (2026-2031)

4.2.3 Global Abdominal Aortic Aneurysm Drug Revenue Market Share by Type (2020-2031)

4.3 Global Abdominal Aortic Aneurysm Drug Price by Type (2020-2031)

5 Segment by Application

5.1 Global Abdominal Aortic Aneurysm Drug Sales by Application (2020-2031)

5.1.1 Global Abdominal Aortic Aneurysm Drug Sales by Application (2020-2025)

5.1.2 Global Abdominal Aortic Aneurysm Drug Sales by Application (2026-2031)

5.1.3 Global Abdominal Aortic Aneurysm Drug Sales Market Share by Application (2020-2031)

5.2 Global Abdominal Aortic Aneurysm Drug Revenue by Application (2020-2031)

5.2.1 Global Abdominal Aortic Aneurysm Drug Revenue by Application (2020-2025)

5.2.2 Global Abdominal Aortic Aneurysm Drug Revenue by Application (2026-2031)

5.2.3 Global Abdominal Aortic Aneurysm Drug Revenue Market Share by Application (2020-2031)

5.3 Global Abdominal Aortic Aneurysm Drug Price by Application (2020-2031)

6 Key Companies Profiled

6.1 AstraZeneca Plc

6.1.1 AstraZeneca Plc Company Information

6.1.2 AstraZeneca Plc Description and Business Overview

6.1.3 AstraZeneca Plc Abdominal Aortic Aneurysm Drug Sales, Revenue and Gross Margin (2020-2025)

6.1.4 AstraZeneca Plc Abdominal Aortic Aneurysm Drug Product Portfolio

6.1.5 AstraZeneca Plc Recent Developments/Updates

6.2 Carolus Therapeutics, Inc.

6.2.1 Carolus Therapeutics, Inc. Company Information

6.2.2 Carolus Therapeutics, Inc. Description and Business Overview

6.2.3 Carolus Therapeutics, Inc. Abdominal Aortic Aneurysm Drug Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Carolus Therapeutics, Inc. Abdominal Aortic Aneurysm Drug Product Portfolio

6.2.5 Carolus Therapeutics, Inc. Recent Developments/Updates

6.3 Novartis AG

6.3.1 Novartis AG Company Information

6.3.2 Novartis AG Description and Business Overview

6.3.3 Novartis AG Abdominal Aortic Aneurysm Drug Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Novartis AG Abdominal Aortic Aneurysm Drug Product Portfolio

6.3.5 Novartis AG Recent Developments/Updates

6.4 Vida Therapeutics Inc.

6.4.1 Vida Therapeutics Inc. Company Information

6.4.2 Vida Therapeutics Inc. Description and Business Overview

6.4.3 Vida Therapeutics Inc. Abdominal Aortic Aneurysm Drug Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Vida Therapeutics Inc. Abdominal Aortic Aneurysm Drug Product Portfolio

6.4.5 Vida Therapeutics Inc. Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Abdominal Aortic Aneurysm Drug Industry Chain Analysis

7.2 Abdominal Aortic Aneurysm Drug Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Abdominal Aortic Aneurysm Drug Production Mode & Process Analysis

7.4 Abdominal Aortic Aneurysm Drug Sales and Marketing

7.4.1 Abdominal Aortic Aneurysm Drug Sales Channels

7.4.2 Abdominal Aortic Aneurysm Drug Distributors

7.5 Abdominal Aortic Aneurysm Drug Customer Analysis

8 Abdominal Aortic Aneurysm Drug Market Dynamics

8.1 Abdominal Aortic Aneurysm Drug Industry Trends

8.2 Abdominal Aortic Aneurysm Drug Market Drivers

8.3 Abdominal Aortic Aneurysm Drug Market Challenges

8.4 Abdominal Aortic Aneurysm Drug Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Astrazeneca plc

Carolus Therapeutics, Inc.

Novartis

Vida Therapeutics Inc.

List of Tables

Table 1. Global Abdominal Aortic Aneurysm Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Abdominal Aortic Aneurysm Drug Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Abdominal Aortic Aneurysm Drug Market Competitive Situation by Manufacturers in 2024

Table 4. Global Abdominal Aortic Aneurysm Drug Sales (K Pcs) of Key Manufacturers (2020-2025)

Table 5. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Abdominal Aortic Aneurysm Drug Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Abdominal Aortic Aneurysm Drug Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Abdominal Aortic Aneurysm Drug Average Price (USD/Pcs) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Abdominal Aortic Aneurysm Drug, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Abdominal Aortic Aneurysm Drug, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Abdominal Aortic Aneurysm Drug, Product Type & Application

Table 12. Global Key Manufacturers of Abdominal Aortic Aneurysm Drug, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Abdominal Aortic Aneurysm Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Abdominal Aortic Aneurysm Drug as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Abdominal Aortic Aneurysm Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Abdominal Aortic Aneurysm Drug Sales by Region (2020-2025) & (K Pcs)

Table 18. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Region (2020-2025)

Table 19. Global Abdominal Aortic Aneurysm Drug Sales by Region (2026-2031) & (K Pcs)

Table 20. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Region (2026-2031)

Table 21. Global Abdominal Aortic Aneurysm Drug Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Abdominal Aortic Aneurysm Drug Revenue Market Share by Region (2020-2025)

Table 23. Global Abdominal Aortic Aneurysm Drug Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Abdominal Aortic Aneurysm Drug Revenue Market Share by Region (2026-2031)

Table 25. North America Abdominal Aortic Aneurysm Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Abdominal Aortic Aneurysm Drug Sales by Country (2020-2025) & (K Pcs)

Table 27. North America Abdominal Aortic Aneurysm Drug Sales by Country (2026-2031) & (K Pcs)

Table 28. North America Abdominal Aortic Aneurysm Drug Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Abdominal Aortic Aneurysm Drug Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Abdominal Aortic Aneurysm Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Abdominal Aortic Aneurysm Drug Sales by Country (2020-2025) & (K Pcs)

Table 32. Europe Abdominal Aortic Aneurysm Drug Sales by Country (2026-2031) & (K Pcs)

Table 33. Europe Abdominal Aortic Aneurysm Drug Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Abdominal Aortic Aneurysm Drug Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Abdominal Aortic Aneurysm Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Abdominal Aortic Aneurysm Drug Sales by Region (2020-2025) & (K Pcs)

Table 37. Asia Pacific Abdominal Aortic Aneurysm Drug Sales by Region (2026-2031) & (K Pcs)

Table 38. Asia Pacific Abdominal Aortic Aneurysm Drug Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Abdominal Aortic Aneurysm Drug Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Abdominal Aortic Aneurysm Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Abdominal Aortic Aneurysm Drug Sales by Country (2020-2025) & (K Pcs)

Table 42. Latin America Abdominal Aortic Aneurysm Drug Sales by Country (2026-2031) & (K Pcs)

Table 43. Latin America Abdominal Aortic Aneurysm Drug Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Abdominal Aortic Aneurysm Drug Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Abdominal Aortic Aneurysm Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Abdominal Aortic Aneurysm Drug Sales by Country (2020-2025) & (K Pcs)

Table 47. Middle East and Africa Abdominal Aortic Aneurysm Drug Sales by Country (2026-2031) & (K Pcs)

Table 48. Middle East and Africa Abdominal Aortic Aneurysm Drug Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Abdominal Aortic Aneurysm Drug Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Abdominal Aortic Aneurysm Drug Sales (K Pcs) by Type (2020-2025)

Table 51. Global Abdominal Aortic Aneurysm Drug Sales (K Pcs) by Type (2026-2031)

Table 52. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Type (2020-2025)

Table 53. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Type (2026-2031)

Table 54. Global Abdominal Aortic Aneurysm Drug Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Abdominal Aortic Aneurysm Drug Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Abdominal Aortic Aneurysm Drug Revenue Market Share by Type (2020-2025)

Table 57. Global Abdominal Aortic Aneurysm Drug Revenue Market Share by Type (2026-2031)

Table 58. Global Abdominal Aortic Aneurysm Drug Price (USD/Pcs) by Type (2020-2025)

Table 59. Global Abdominal Aortic Aneurysm Drug Price (USD/Pcs) by Type (2026-2031)

Table 60. Global Abdominal Aortic Aneurysm Drug Sales (K Pcs) by Application (2020-2025)

Table 61. Global Abdominal Aortic Aneurysm Drug Sales (K Pcs) by Application (2026-2031)

Table 62. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Application (2020-2025)

Table 63. Global Abdominal Aortic Aneurysm Drug Sales Market Share by Application (2026-2031)

Table 64. Global Abdominal Aortic Aneurysm Drug Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Abdominal Aortic Aneurysm Drug Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Abdominal Aortic Aneurysm Drug Revenue Market Share by Application (2020-2025)

Table 67. Global Abdominal Aortic Aneurysm Drug Revenue Market Share by Application (2026-2031)

Table 68. Global Abdominal Aortic Aneurysm Drug Price (USD/Pcs) by Application (2020-2025)

Table 69. Global Abdominal Aortic Aneurysm Drug Price (USD/Pcs) by Application (2026-2031)

Table 70. AstraZeneca Plc Company Information

Table 71. AstraZeneca Plc Description and Business Overview

Table 72. AstraZeneca Plc Abdominal Aortic Aneurysm Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 73. AstraZeneca Plc Abdominal Aortic Aneurysm Drug Product

Table 74. AstraZeneca Plc Recent Developments/Updates

Table 75. Carolus Therapeutics, Inc. Company Information

Table 76. Carolus Therapeutics, Inc. Description and Business Overview

Table 77. Carolus Therapeutics, Inc. Abdominal Aortic Aneurysm Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 78. Carolus Therapeutics, Inc. Abdominal Aortic Aneurysm Drug Product

Table 79. Carolus Therapeutics, Inc. Recent Developments/Updates

Table 80. Novartis AG Company Information

Table 81. Novartis AG Description and Business Overview

Table 82. Novartis AG Abdominal Aortic Aneurysm Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 83. Novartis AG Abdominal Aortic Aneurysm Drug Product

Table 84. Novartis AG Recent Developments/Updates

Table 85. Vida Therapeutics Inc. Company Information

Table 86. Vida Therapeutics Inc. Description and Business Overview

Table 87. Vida Therapeutics Inc. Abdominal Aortic Aneurysm Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 88. Vida Therapeutics Inc. Abdominal Aortic Aneurysm Drug Product

Table 89. Vida Therapeutics Inc. Recent Developments/Updates

Table 90. Key Raw Materials Lists

Table 91. Raw Materials Key Suppliers Lists

Table 92. Abdominal Aortic Aneurysm Drug Distributors List

Table 93. Abdominal Aortic Aneurysm Drug Customers List

Table 94. Abdominal Aortic Aneurysm Drug Market Trends

Table 95. Abdominal Aortic Aneurysm Drug Market Drivers

Table 96. Abdominal Aortic Aneurysm Drug Market Challenges

Table 97. Abdominal Aortic Aneurysm Drug Market Restraints

Table 98. Research Programs/Design for This Report

Table 99. Key Data Information from Secondary Sources

Table 100. Key Data Information from Primary Sources

Table 101. Authors List of This Report

List of Figures

Figure 1. Product Picture of Abdominal Aortic Aneurysm Drug

Figure 2. Global Abdominal Aortic Aneurysm Drug Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Abdominal Aortic Aneurysm Drug Market Share by Type: 2024 & 2031

Figure 4. BSN-908 Product Picture

Figure 5. Canakinumab Product Picture

Figure 6. CT-2009 Product Picture

Figure 7. Ticagrelor Product Picture

Figure 8. Others Product Picture

Figure 9. Global Abdominal Aortic Aneurysm Drug Market Value by Application (2020-2031) & (US$ Million)

Figure 10. Global Abdominal Aortic Aneurysm Drug Market Share by Application: 2024 & 2031

Figure 11. Hospital

Figure 12. Clinic

Figure 13. Others

Figure 14. Global Abdominal Aortic Aneurysm Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Abdominal Aortic Aneurysm Drug Market Size (2020-2031) & (US$ Million)

Figure 16. Global Abdominal Aortic Aneurysm Drug Sales (2020-2031) & (K Pcs)

Figure 17. Global Abdominal Aortic Aneurysm Drug Average Price (USD/Pcs) & (2020-2031)

Figure 18. Abdominal Aortic Aneurysm Drug Report Years Considered

Figure 19. Abdominal Aortic Aneurysm Drug Sales Share by Manufacturers in 2024

Figure 20. Global Abdominal Aortic Aneurysm Drug Revenue Share by Manufacturers in 2024

Figure 21. Global 5 and 10 Largest Abdominal Aortic Aneurysm Drug Players: Market Share by Revenue in Abdominal Aortic Aneurysm Drug in 2024

Figure 22. Abdominal Aortic Aneurysm Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 23. Global Abdominal Aortic Aneurysm Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 24. North America Abdominal Aortic Aneurysm Drug Sales Market Share by Country (2020-2031)

Figure 25. North America Abdominal Aortic Aneurysm Drug Revenue Market Share by Country (2020-2031)

Figure 26. U.S. Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Canada Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. Europe Abdominal Aortic Aneurysm Drug Sales Market Share by Country (2020-2031)

Figure 29. Europe Abdominal Aortic Aneurysm Drug Revenue Market Share by Country (2020-2031)

Figure 30. Germany Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. France Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. U.K. Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Italy Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Russia Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Asia Pacific Abdominal Aortic Aneurysm Drug Sales Market Share by Region (2020-2031)

Figure 36. Asia Pacific Abdominal Aortic Aneurysm Drug Revenue Market Share by Region (2020-2031)

Figure 37. China Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Japan Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. South Korea Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. India Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Australia Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Taiwan Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Indonesia Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Thailand Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Malaysia Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Philippines Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Latin America Abdominal Aortic Aneurysm Drug Sales Market Share by Country (2020-2031)

Figure 48. Latin America Abdominal Aortic Aneurysm Drug Revenue Market Share by Country (2020-2031)

Figure 49. Mexico Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Brazil Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Argentina Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Middle East and Africa Abdominal Aortic Aneurysm Drug Sales Market Share by Country (2020-2031)

Figure 53. Middle East and Africa Abdominal Aortic Aneurysm Drug Revenue Market Share by Country (2020-2031)

Figure 54. Turkey Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Saudi Arabia Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. UAE Abdominal Aortic Aneurysm Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 57. Global Sales Market Share of Abdominal Aortic Aneurysm Drug by Type (2020-2031)

Figure 58. Global Revenue Market Share of Abdominal Aortic Aneurysm Drug by Type (2020-2031)

Figure 59. Global Abdominal Aortic Aneurysm Drug Price (USD/Pcs) by Type (2020-2031)

Figure 60. Global Sales Market Share of Abdominal Aortic Aneurysm Drug by Application (2020-2031)

Figure 61. Global Revenue Market Share of Abdominal Aortic Aneurysm Drug by Application (2020-2031)

Figure 62. Global Abdominal Aortic Aneurysm Drug Price (USD/Pcs) by Application (2020-2031)

Figure 63. Abdominal Aortic Aneurysm Drug Value Chain

Figure 64. Channels of Distribution (Direct Vs Distribution)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Coronary Imaging Catheter Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32P14840

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Point-of-care Troponin Testing Instrument Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22I19939

Wed Nov 19 00:00:00 UTC 2025

Add to Cart

Global Troponin Analyzer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-38W19812

Wed Nov 19 00:00:00 UTC 2025

Add to Cart

Global Anticoagulant Medications Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-39V16824

Wed Nov 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions